Business Wire

Imperva API Security Makes It Easier to Monitor and Discover APIs to Eliminate Data Leakage and API Abuses

Share

Imperva, Inc. (@Imperva), the comprehensive digital security leader on a mission to help organizations protect their data and all paths to it, introduces at Imperva Amplify 2022 the availability of Imperva API Security with continuous API discovery and data classification. The product is deployed easily in any environment to provide visibility and protection of data across legacy and cloud-native applications. As a service offering, it can be seamlessly enabled by Imperva Cloud Web Application Firewall (WAF) customers or quickly deployed as a standalone to gain visibility into all API traffic.

Imperva API Security provides protection for Application Programming Interfaces (APIs) in developer environments that often lack adequate security controls and are vulnerable to malicious or inadvertent exposure. According to Gartner®, “By 2024, API abuses and related data breaches will nearly double,” predicts Mark O’Neil and Shameen Pillai, in the May 2021 report, “The 10 Things Software Engineering Leaders Need to Know About APIs1.”

The volume of APIs are multiplying as organizations accelerate digital transformation and adopt modern application development approaches. The proportion of web traffic flowing from APIs has grown 30% in 2022, compared to the same period last year, according to an analysis of cloud WAF traffic by Imperva Research Labs. As the volume of API traffic increases, it becomes a greater threat to an organization’s sensitive data. Motivated attackers will increasingly target APIs as the pathway to the underlying infrastructure and database. Imperva API Security enables rapid, secure development by providing continuous visibility and protection for all APIs. The product mitigates the risk of data breaches and data leakage by uncovering shadow APIs, and suggests remediation for software developers and security administrators.

Key Benefits of Imperva API Security:

  • Identify and classify data flowing through any API: Protecting APIs should be a direct extension of an organization’s strategy for securing sensitive data. Imperva API Security automatically discovers each API’s full schema while identifying and classifying the data that flows through it.
  • Continuous discovery of APIs and schema changes: With a simple activation, REST APIs are quickly detected to enable creation of a positive security model. API inventories are automatically updated, helping the security team keep pace with developers who frequently modify APIs in production.
  • Flexible deployment model: Imperva API Security works across legacy, hybrid, and cloud-native environments including: Kubernetes, legacy monolithic apps, standalone microservices, web proxies, or API gateways that integrate with other existing infrastructure. The flexible deployment model provides protection for both public-facing and backend APIs in a single solution without slowing down development teams.
  • Enable API governance: Gain visibility beyond the API endpoint and into each API’s underlying payload. This context will help business leaders in highly regulated industries enforce a governance model and stop a potential data breach.

“Organizations need a new approach for protecting APIs as attacks multiply and increase in sophistication,” says Karl Triebes, SVP, Product Management & General Manager, Application Security, Imperva. “Simply knowing how many APIs you have in your environment isn’t enough. With the focus on protecting the underlying data, Imperva API Security is designed to help security and development teams work cooperatively without altering code or slowing down the development lifecycle.”

Imperva API Security is a product uniquely designed to benefit both the security and development teams. As a core component of the market-leading Imperva Web Application & API Protection platform, customers can protect critical applications and infrastructure from online fraud, DDoS attacks, and API abuses.

“Managing the security of APIs is one of the key business risks organizations face today as they accelerate the pace of software development,” says Christopher Rodriguez, Research Director, Cybersecurity Products at IDC. “Protecting APIs should be seen as a critical dimension of a strong data security strategy. API security tools should provide the ability to discover and classify every API in and out of production. Organizations must act quickly as APIs will be the source of more data breaches in the coming years.”

Additional Information:

  • See how Imperva API Security can protect your APIs across legacy, hybrid, and cloud-native environments
  • Check out the Imperva Blog for the latest product and solution news, and threat intelligence from Imperva Research Labs
  • Contact Imperva if you’re looking for a solution to mitigate API-related security risks

About Imperva:

Imperva is the comprehensive digital security leader on a mission to help organizations protect their data and all paths to it. Only Imperva protects all digital experiences, from business logic to APIs, microservices, and the data layer, and from vulnerable, legacy environments to cloud-first organizations. Customers around the world trust Imperva to protect their applications, data, and websites from cyber attacks. With an integrated approach combining edge, application security, and data security, Imperva protects companies ranging from cloud-native start-ups to global multinationals with hybrid infrastructure. Imperva Threat Research and our global intelligence community keep Imperva ahead of the threat landscape and seamlessly integrate the latest security, privacy, and compliance expertise into our solutions.

© 2022 Imperva, Inc. All rights reserved. Imperva is a registered trademark of Imperva, Inc.

____________________

1 Gartner, The 10 Things Software Engineering Leaders Need to Know About APIs, Published 27 May 2021, Shameen Pillai and Mark O’Neil

Gartner is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jonathan Gregalis
impervaPR@imperva.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Starr Insurance Companies Expands in Thailand17.5.2022 22:33:00 CEST | Press release

Starr Insurance Companies (Starr) announced an agreement with FPG Insurance Holdings Limited (HK) (FPG) and local Thai shareholders to purchase FPG Insurance Public Company Limited (FPG Thailand), a Thai non-life insurance company, together with local Thai parties. Starr’s investment will be held by its Bermuda insurance company, Starr Insurance & Reinsurance Limited. The transaction is expected to close in the second quarter of 2022, subject to certain customary closing conditions, including any necessary regulatory approvals. “Thailand is an important, fast-growing insurance market — one of the cornerstones of the Southeast Asia economy,” said Maurice R. Greenberg, Starr’s Chairman & CEO. “Asia is both commercially and culturally important to Starr, as we trace our roots to an American-owned company founded in Shanghai more than 100 years ago. We look forward to serving the needs of local Thai companies and consumers through this new insurance capability.” David Zuellig, FPG regional

Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE -related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting17.5.2022 22:15:00 CEST | Press release

Emendo Biotherapeutics presented the results of its next generation CRISPR-based gene editing approaches for several indications in an oral presentation and three posters at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) held May 16-19, 2022, in Washington, D.C. Emendo presented pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, demonstrating the power of Emendo’s dual technology platforms that enable the development of a highly specific editing composition that demonstrates no off-targets and complete allele specificity. Significantly, the lack of off-target achieved by Emendo’s engineered and optimized OMNI nuclease also eliminated any translocations. Edited patient derived CD34+ cells differentiated normally into neutrophils both in-vitro and in-vivo, showing full engraftment and reconstitution of all blood lineages, as required for the desired therapeutic effect. “ELANE-based

Piper Sandler Advises PETRONAS Chemicals Group Berhad on Acquisition of Perstorp17.5.2022 19:59:00 CEST | Press release

Piper Sandler & Co. chemicals investment banking announced today that it has advised PETRONAS Chemicals Group Berhad (PCG) on its acquisition of Perstorp Holding AB. The transaction Enterprise Value is €2,300 million and base purchase price, less adjusted net debt, is €1,538 million. It is expected to close in Q3 2022 subject to customary closing conditions. PCG is the leading integrated chemicals producer in Malaysia and one of the largest in Southeast Asia. It operates a number of world-class production sites, which are fully vertically integrated from feedstock to downstream end-products. With a total combined production capacity of 12.8 million metric tons per annum (mtpa), it is involved primarily in manufacturing, marketing, and selling a diversified range of chemical products, including olefins, polymers, fertilizers, methanol and other basic chemicals and derivative products. Listed on Bursa Malaysia in 2010 and with more than three decades of experience in the chemicals indust

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods17.5.2022 19:53:00 CEST | Press release

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Bifidobacterium longum BB536 was approved by the National Health Commission (NHC) of the People’s Republic of China as a new food ingredient for use in infant and toddler foods (under the age of three) on 11th May 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005112/en/ Morinaga Milk obtains the registration of "New Food Ingredient" in China for use of its probiotic Bifidobacterium longum BB536 in infant and toddler foods on 11th May 2022. (Graphic: Business Wire) Following a complex and lengthy registration process, the probiotic strain B. longum BB536 meets the highest standards of safety and regulatory compliance and has now completed the approval process for use as an ingredient in infant and toddler milk and food products for children under three years old in China. “We are extr

Hiro Capital Joins Knollwood and Boost VC With Major Investment in Skybound Entertainment17.5.2022 19:30:00 CEST | Press release

Hiro Capital has invested in Skybound Entertainment in a significant, undisclosed round led by Knollwood Advisory with participation from Boost VC, and follow-on participation from Com2uS and Skydance Entertainment. Skybound Entertainment is home to acclaimed franchises including The Walking Dead, Invincible, and Impact Winter. “There is nothing more powerful than storytelling, and I’m delighted that Hiro has been able to invest in Skybound Entertainment, creators and curators of extremely compelling omniverses,” said Sir Ian Livingstone, Co-Founding Partner of Hiro Capital. “Hiro’s trust in our vision will help us accelerate the evolution of existing hit franchises as well as new content for our fan base around the world,” said Skybound CEO David Alpert. Skybound brings together creators across its multi-faceted business, including comics, interactive games, audio, film, and television (traditional and digital platforms), licensing, and merchandising. Skybound has successfully franchi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom